Maze Therapeutics, Inc. (MAZE)

Maze Therapeutics Revenue

Maze Therapeutics had revenue of $2.50M in the twelve months ending June 30, 2025, down -98.48% year-over-year. In the year 2024, Maze Therapeutics had annual revenue of $167.50M.

• Revenue (ttm): $2.50M
• Revenue Growth: -98.48%
• P/S Ratio: 126.42
• Revenue / Employee: $20,000
• Employees: 125
• Market Cap: 705.56M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	167.50M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.